Endo subsidiary to acquire Indevus

CHADDS FORD, Pa. Endo Pharmaceuticals will acquire Indevus Pharmaceuticals, Endo announced Thursday.

Endo said its subsidiary, BTB Purchaser, had completed a tender offer to acquire 89.15% of shares in Indevus, and that it will complete its acquisition by merging BTB into Indevus, with Indevus continuing as a wholly owned subsidiary of Endo.

Exact financial terms of the deal were not disclosed, though the merger is expected to occur within the next several days, Endo said.

Login or Register to post a comment.